Biofrontera Pharma GmbH

AMELUZ

Pharmaceutical preparations for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; pharmaceutical preparations for skin rejuvenation; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for wound healing; pharmaceutical preparations for the treatment of acne vulgaris; pharmaceutical preparations for anti-bacterial therapy; [ sanitary preparations for medical use; fungicides, herbicides; media for bacteriological cultures; ] bacteriological preparations for medical purposes; biological preparations for medical purposes, namely, skin disorders and skin cancers; biochemical preparations for medical purposes, namely, skin disorders and skin cancers; [ enzymes for medical purposes; ] ferments for pharmaceutical purposes; [ vaccines; nutritive substances for microorganisms for medical purposes; chemical preparations for sanitary purposes; ] chemical reagants for medical purposes; [ chemical preparations for sanitary use; ]medicines for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; medicines for skin rejuvenation; medicines for the treatment of psoriasis; medicines for wound healing; medicines for the treatment of acne vulgaris; medicines for anti-bacterial therapy; medicated ointments and gels for the treatment of skin disorders and skin cancers;The wording AMELUZ has no meaning in a foreign language.;

BELIXOS

The following all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements should be inserted at end of the class.;Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements * ] * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements *;Line 15 through 22, all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements should be deleted, and all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements should be inserted.;

BELIXOS

Cosmetics; cosmetic skin care products, cosmetic skin creams, cosmetic skin care lotion, cosmetic skin care gels;The wording BELIXOS has no meaning in a foreign language.;

BF-RHODOLED

[ Surgical apparatus and instruments for medical, dental, or veterinary use; artificial limbs, eyes and teeth; suture materials; ] ultraviolet, infrared and visible light lamps for medical purposes; ultraviolet, infrared and visible light irradiation lamps for treatment of skin irritations and skin disease;

NATURAL HERITAGE WITH HERBAL BIOCOLLOIDS

The mark consists of a circular map of the world with a gray background and where the continents appear in green, light green, dark green and yellow consisting of green leaves and yellow flowers. Around the circle are the words NATURAL HERITAGE WITH HERBAL BIOCOLLOIDS in gray on a white background.;Cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils for personal use, cosmetics, hair lotions; dentifrices; cosmetic preparations for skin care; cosmetic creams; cosmetic skin care lotion; cosmetic skin care gels for the prevention and/or treatment of skin irritations or skin diseases;The color(s) gray, white, green, light green, dark green, and yellow is/are claimed as a feature of the mark.;HERBAL BIOCOLLOIDS;